http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Novavax Reports Fourth Quarter and Year-End 2018 Financial Results
-
Novavax Reports Fourth Quarter and Year-End 2018 Financial Results
-
Novavax to Host Conference Call to Discuss Fourth Quarter and Year-End 2018 Financial Results on March 18, 2019
-
Novavax to Host Conference Call to Discuss Fourth Quarter and Year-End 2018 Financial Results on March 18, 2019
-
Novavax (NVAX) Phase 3 Prepare Trial of ResVax for Prevention of RSV Disease in Infants Doesn't Meet Primary Endpoint
-
Novavax Announces Topline Results from Phase 3 PrepareTM Trial of ResVax™ for Prevention of RSV Disease in Infants via Maternal Immunization
-
Novavax Announces Topline Results from Phase 3 PrepareTM Trial of ResVax™ for Prevention of RSV Disease in Infants via Maternal Immunization
-
Novavax (NVAX) Announces Positive NanoFlu Phase 2 Results for Adults 65 or Older
-
Novavax Announces Positive Phase 2 NanoFlu Results in Older Adults
-
Novavax Announces Positive Phase 2 NanoFlu Results in Older Adults
-
Novavax to Present at the 37th Annual J.P. Morgan Healthcare Conference
-
Novavax to Present at the 37th Annual J.P. Morgan Healthcare Conference
-
Novavax Announces Leadership Promotions
-
Novavax Announces Leadership Promotions
-
Novavax Expands Leadership with Several Key Management Promotions
-
Novavax Expands Leadership with Several Key Management Promotions
-
Novavax Reports Third Quarter 2018 Financial Results
-
Novavax Reports Third Quarter 2018 Financial Results
-
Novavax (NVAX) Names Rachel King to Board
-
Novavax to Host Conference Call to Discuss Third Quarter Financial Results on November 7, 2018
-
Novavax to Host Conference Call to Discuss Third Quarter Financial Results on November 7, 2018
-
Novavax Appoints Rachel King to Board of Directors
-
Novavax Appoints Rachel King to Board of Directors
-
Novavax to Highlight RSV Program Data at Two Upcoming Meetings
-
Novavax to Highlight RSV Program Data at Two Upcoming Meetings
-
Novavax to Present at Two Upcoming Investor Conferences
-
Novavax to Present at Two Upcoming Investor Conferences
-
Novavax (NVAX) Reports Commencement of Phase 2 Clinical Trial of NanoFlu in Older Adults
-
Novavax Initiates Phase 2 Clinical Trial of NanoFlu™ in Older Adults
-
Novavax Initiates Phase 2 Clinical Trial of NanoFlu™ in Older Adults
-
Novavax to Participate at Two Upcoming Investor Conferences
-
Novavax to Participate at Two Upcoming Investor Conferences
-
Novavax Reports Second Quarter 2018 Financial Results
-
Novavax Reports Second Quarter 2018 Financial Results
-
After-Hours Stock Movers 11/09: (SHAK) (OMER) (TASR) Higher; (HLIT) (AVID) (TWTR) Lower (more...)
-
Pre-Open Stock Movers 09/16: (DEPO) (INTC) (GPRO) Higher; (NVAX) (DB) (ORCL) Lower (more...)
-
Pre-Open Stock Movers 01/25: (AFMD) (GRUB) (SUNE) (TYC) Higher; (OMED) (NVAX) (TWTR) Lower (more...)
-
Novavax (NVAX) Gains Ahead of Appeance on Mad Money
-
Pre-Open Stock Movers 06/05: (NEWL) (CIEN) (HALO) Higher; (NVAX) (RAD) (RCAP) Lower (more...)

